Aviva PLC Seagen Inc. Transaction History

Aviva PLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$191.51 - $216.16 $12.3 Million - $13.8 Million	-64,053 Reduced 48.41%	68,269 $14.5 Million
Q2 2023 Aug 10, 2023	BUY	$187.64 - $206.25 $23.9 Million - $26.2 Million	127,144 Added 2455.47%	132,322 $25.5 Million
Q1 2023 May 12, 2023	SELL	$127.59 - $203.08 $3.91 Million - $6.23 Million	-30,674 Reduced 85.56%	5,178 $1.05 Million
Q4 2022 Feb 09, 2023	SELL	$117.37 - $139.17 $2.93 Million - $3.48 Million	-24,979 Reduced 41.06%	35,852 $4.61 Million
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $36,117 - $48,089	267 Added 0.44%	60,831 $8.32 Million
Q2 2022 Aug 04, 2022	BUY	$108.81 - $179.33 $4.02 Million - $6.62 Million	36,901 Added 155.94%	60,564 $10.7 Million
Q1 2022 May 13, 2022	SELL	$119.61 - $157.85 $90,664 - $119,650	-758 Reduced 3.1%	23,663 $3.41 Million
Q4 2021 Feb 10, 2022	SELL	$142.57 - $190.86 $1.37 Million - $1.83 Million	-9,607 Reduced 28.23%	24,421 $3.78 Million
Q3 2021 Nov 12, 2021	SELL	$142.45 - $169.82 $1.67 Million - $1.99 Million	-11,732 Reduced 25.64%	34,028 $5.78 Million
Q2 2021 Aug 10, 2021	SELL	$135.08 - $161.1 $565,715 - $674,686	-4,188 Reduced 8.38%	45,760 $7.23 Million
Q1 2021 May 13, 2021	BUY	$137.51 - $190.8 $311,047 - $431,589	2,262 Added 4.74%	49,948 $6.94 Million
Q4 2020 Feb 10, 2021	BUY	$164.63 - $211.93 $7.85 Million - $10.1 Million	47,686 New	47,686 $8.35 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

Stay updated on Aviva PLC with notifications on news.